en

PRODUCT DETAIL

REYATAZ 50 mg perorálny prášok

Code 0340C
MA number EU/1/03/267/012
Product Form: plv por 30x50 mg (vre.PET/Al/PE)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 42 - CHEMOTHERAPEUTICA (VRATANE TUBERKULOSTATIK)
ATC:
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AE Protease inhibitors
J05AE08 Atazanavir
Shelf life: 36
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - known active substance
MA issued: 02.03.2004
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 30.06.2021
eu-flag.png sk-flag.png